"As their lungs filled … the patients became short of breath and increasingly cyanotic. After gasping for several hours they became delirious and incontinent, and many died struggling to clear their airways of a blood-tinged froth that sometimes gushed from their nose and mouth. It was a dreadful business."
http://www.ninthday.com/spanish_flu.htm
http://jama.ama-assn.org/issues/v288n19/ffull/jmn1120-1.html
"In the midst of perfect health, in a circumscribed community... the first case of influenza would occur, and then within the next few hours or days a large proportion- and occasionally every single individual of that community- would be stricken down with the same type of febrile illness, the rate of spread from one to another being remarkable... Barrack rooms which the day before had been full of bustle and life, would now converted wholesale into one great sick room, the number of sick developing so rapidly that hospitals were within a day or two so overfull that fresh admissions were impossible."
- Dr. Herbert French to the British Ministry of Health (Hoehling,18)
http://www.haverford.edu/biology/edwards/disease/viral_essays/cummingsvirus.htm
http://www.cdc.gov/od/nvpo/pandemics/flu3.htm
http://www.bath.ac.uk/~ns0sjcg/website/P4.html
Influenza is not just a bad cold
Influenza is essentially an acute respiratory illness caused by the influenza viruses A, B and C. Whereas the common cold virus has mutated to about two hundred and fifty strains, the influenza virus has only mutated to about ten to twenty strains but this renders it no less effective. A shared characteristic of the common cold and the influenza viruses is that they are both carried in respiratory secretions and distributed by coughs and sneezes. Once infected with the influenza virus, the patient may suffer from a sore throat, a dry cough, a runny or stuffy nose, headache, wide spread muscle ache, a high temperature, shivering, painful, watery eyes and extreme fatigue. These symptoms are quite different from those of the common cold and leave the patient more vulnerable to developing complications such as secondary bacterial pneumonia, which is most often the lethal factor. Autopsies of flu victims reveal swollen, wet lungs filled with large quantities of thin, bloody fluid.
The structure of the virus particle is fairly unique (see fig. i) and fig. ii)). The centre contains eight strands of genetic material, ribose nucleic acid (RNA) surrounded by a protein coat. The entire virus is surrounded by another coat called the matrix protein membrane and then a lipid (fatty) layer. Through this layer protrude spikes of two different types of protein molecules, haemagglutinin and neuraminidase which aid the virus in attaching to and entering the cell it infects. The body recognises these two proteins as foreign and attacks the virus with antibodies. If the virus never changed, the antibodies produced during infection could be used to make a vaccine to immunise against this illness. However, the influenza virus is a mutating creature and so it is not possible to make a single vaccine that can treat all strains of the virus.
The virus hits hard and fastThe influenza virus is very good at making spontaneous and uncontrollable attacks thanks to its ability to mutate quickly. Minor changes in the protein antigens found on the surface of the influenza virus particle (antigenic drift) mean that the virus, in effect, changes from one season to the next. Consequently, having suffered from flu once does not make the patient immune to the virus when exposed to it a second time. It is also very quick to act. Having infected the cells of the respiratory passages, viral replication takes place within four to six hours and the virus is released to infect nearby cells. The patient is ill between eighteen to seventy two hours later.
If only minor mutations occur the symptoms may not be as severe the second time a patient is infected, since the body recognises some of the surface proteins and can produce some effective antigens. However, influenza occasionally undergoes major antigenic ‘shift’ independent of season and this gives rise to pandemics, or worldwide epidemics. Antigenic shift is when totally new haemagglutinin spikes and sometimes neuraminidase molecules too are formed. This happens via the mixing of two viral strains in a host cell, as opposed to the simple genetic mutation which occurs during antigenic drift. The lack of immunity to this new virus results in large portions of the population being affected.
However, the unpredictability and speed of mutation of the virus is not the only deadly feature of influenza. The influenza virus A, the type associated with occurrence of epidemics, has the ability to acquire new antigens from other influenza A subtypes including those of avian origin. The viruses causing the major three pandemics last century are thought to have originated from pigs or birds. These strains are particularly dangerous because there is little or no natural immunity and so the virus spreads quickly and over a large area. This poses questions about the safety of xenotransplantation (the transplantation of animal organs into humans) and genetic engineering. As yet we do not have the benefit of retrospect, these being relatively new areas of science, so we cannot predict what the result of such experiments will be. We could be engineering the perfect conditions for a lethal influenza pandemic.
Every thirty to forty years, a new, aggressive influenza virus emerges to which we have no natural defence and which often escalates to epidemic proportions. In order that epidemic status be declared, four hundred out of every one hundred thousand people must be infected. In the case of the influenza virus, epidemic proportions have been surpassed on several occasions, (thirty one times since 1580), and a pandemic has been declared. Epidemics, and pandemics in particular, have serious political and economical consequences. When such a large percentage of the population becomes ill, the country where the virus strikes will suffer economic damage, productivity losses and huge medical expenses, not to mention a great strain on the national health service such as was seen last winter in Britain. Therefore, influenza epidemics and pandemics are documented throughout history.
Several factors have been identified as likely causes or ‘sparks’ of an epidemic:-
The first three factors given above are probably the most relevant to the spread of influenza. For example, two out of the three influenza pandemics last century, the ‘Asian Flu’ in 1957 and the ‘Hong Kong Flu’ in 1968 both started in Asia but quickly spread to the west due to travel. Probably the most famous influenza pandemic and certainly the most staggering was that of the ‘Spanish Flu’ pandemic between 1918 and 1920. This struck at the end of the First World War and killed at least twenty five million people in one year. This is far more than the nine million people killed by the war during four years of combat so one can appreciate just how dangerous the influenza virus is. As one source says, "A trenchmate’s sneeze carrying virus particles could contain more killing power than an enemy’s bullet." Once again, the spread of the virus was due to travel, infected troops being sent all over the world. The ships became floating hospitals instead of battle ships and many of the soldiers died at sea before they even saw the front line. Those that survived carried the virus onto the battlefield and it very quickly spread to Italy, Germany and France. The success of this particular outbreak was due to the constant movement of troops and the unusual situation of hundreds of men living together in a confined area.
This was also the first time that this particular virus had appeared since we now know that it was a strain of avian influenza. It had been passed onto pigs, had mutated to overcome the swine immune system and then passed onto humans. Therefore human immunity to this particular strain was low, if not non-existent. Similarly, only two years ago, an avian flu outbreak in Hong Kong caused wide spread concern about the possibility of a new, very deadly pandemic. Eighteen people were diagnosed as being infected with this strain of influenza, of which six died. However, it was a very localised attack and it disappeared as quickly as it had appeared, characteristic of influenza outbreaks. It is thought that a visiting market stall selling chickens introduced the virus since it could only enter humans directly from the infected birds. There was no human to human transmission. If this strain of influenza had increased to pandemic proportions, it would have killed thirty per cent of the world’s population before a vaccine could have been developed to protect those who had escaped infection. This shows just how unprepared we are for new influenza epidemics.
Successful treatmentInfluenza’s most deadly weapon is that the human body is not good at recognising the mutated forms of the virus and therefore our immune system cannot often fight infection successfully. Normal treatment includes bed rest and paracetamol and if possible, isolation to prevent spread of infection. Several attempts have been made at developing some form of medication. However, due to the mutating nature of the influenza virus, it is very difficult to make a single comprehensive medication. The vaccine in use at the moment is produced by injecting the virus into fertilised chicken eggs, harvesting the resulting viral particles from the embryos and inactivating them to create a vaccine. However the make up of the vaccine has to be changed each year to target the particular strain in circulation at that time. The content of the vaccine is decided upon as in figure iv). The dependence on fertilised eggs is a constraint to the production of the vaccine and therefore when epidemics strike it is difficult to obtain large enough volumes of the required vaccine to protect the population. As part of its plan for pandemics, the World Health Organisation, WHO, stimulates vaccine research on tissue culture and other such techniques. It is hoped that this will speed up production of the vaccine when serious, unforeseen circumstances make the provision of large amounts of vaccine necessary.
The use of the antiviral drugs Amantadine and its derivative Rimantadine has also been considered. These are only effective against the influenza A virus and development of resistance occurs quickly, making them less than ideal in epidemic circumstances. However, they reduce the severity and duration of the illness when taken within 48 hours of appearance of symptoms and are used to treat high-risk patients and the elderly. Recently, though, there has been some development in the field of antivirals. A new class of medicines called neuraminidase inhibitors, for example Relenza, aim to treat the underlying cause of influenza, instead of just the symptoms. They work by targeting and selectively inhibiting the viral enzyme neuraminidase. This seems to be very effective and is not diminished by antigenic shift so this could possibly be the future of influenza treatment. Other developments such as live vaccines and DNA vaccines are possible alternatives.
The WHO’s pandemic planThe treatment of influenza is only part of the WHO’s plan for Global Management and Control of an Influenza Pandemic. Surveillance plays a major role in this plan. Every month, one hundred and ten National Influenza Centres in eighty-three countries are required to report to the WHO any incidence of influenza so that any potential epidemics are spotted and dealt with before they become a problem. It has called for each national health authority to develop its own national pandemic emergency response plan which may include stockpiling drugs and vaccines as in Australia. However, so far less than a dozen countries have completed their plans. Even the United States of America has only a draft plan despite the fact that a team at the US Centres for Disease Control and Prevention (CDC) has predicted that the next pandemic could kill up to 200,000 people in the US alone.
ConclusionIt is very rare to meet someone who has never suffered with the flu at some point in his life. The influenza virus is an extremely contagious and dangerous and is, at the moment, virtually unstoppable. We have all the evidence we need from history to prove that influenza is a serious health risk and demands great respect. Unfortunately, it seems that not enough people realise just how dangerous influenza is and that is why the possibility of new epidemics or even a pandemic is very real. The surveillance program and vaccination program run by WHO are extremely worthwhile but they are only as good as the countries taking part. The lack of action frustrates those who are working on the action plans. Martin Meltzer, a CDC official working on the US action plan says, "The next pandemic could begin anywhere at any time. We need better surveillance now, and it’s not happening." Unless all the flu pandemic plans are finalised, there will be no benefit since the virus will spread with ease amongst the populations where no action is being taken. There is a need for more public awareness. Something good which may have come out of last winter’s flu epidemic in Britain is that people will remember, for example, the horrors of seeing cooler trucks acting as mortuaries and be more aware of the power of this lethal virus. We must never forget the absolute power of influenza, an epidemic waiting to happen.
http://www.bath.ac.uk/~ns0nks/Fluwelcome.html